The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target
about
Nicotinamide adenine dinucleotide (NAD) may affect DNA methyltransferase 1 through regulation of BRCA1 in ovarian cancer.TAp73 transcriptionally represses BNIP3 expression.BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancerThe NAD(+) salvage pathway modulates cancer cell viability via p73.Nicotinamide Mononucleotide Adenylyl Transferase 2: A Promising Diagnostic and Therapeutic Target for Colorectal Cancer.p53, DNA damage, and NAD+ homeostasis.
P2860
The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The NAD+ synthesizing enzyme n ...... -2) is a p53 downstream target
@en
type
label
The NAD+ synthesizing enzyme n ...... -2) is a p53 downstream target
@en
prefLabel
The NAD+ synthesizing enzyme n ...... -2) is a p53 downstream target
@en
P2093
P2860
P356
P1433
P1476
The NAD+ synthesizing enzyme n ...... -2) is a p53 downstream target
@en
P2093
Derek Clements
Lu-Zhe Pan
Patrick W K Lee
Shashi A Gujar
Tanveer Sharif
P2860
P304
P356
10.4161/CC.28128
P50
P577
2014-02-07T00:00:00Z